Study Guide: Inflammatory and Rheumatological Diseases
Inflammatory and Rheumatological Diseases
Introduction to Inflammatory and Rheumatological Diseases
- Focus of next series of lectures.
- Familiarity due to prior discussions on the immune system.
- Inflammatory diseases affect multiple body systems.Context of Joint Pain
- Topic introduced with common patient complaint: "my joints hurt."
- Various possible diagnoses discussed, but no exhaustive list to be covered.
- Focus on common diseases, starting with rheumatoid arthritis.
Autoimmune Rheumatic Diseases
Definition and Characteristics
- Autoimmune rheumatic diseases:
- Group of chronic disorders.
- Characterized by diffuse inflammatory lesions and degenerative changes.
- Primarily affect connective tissues leading to pain.Importance of Terminology
- Familiar terms such as neutrophils and cytokines critical to understanding pathophysiology and etiology.
Rheumatoid Arthritis (RA)
Presentation and Symptoms
- Patient example: presenting symptoms of pain and stiffness, particularly in the morning.
- Typical symptoms include:
- Polyarticular pain and swelling.
- Systemic inflammation leading to:
- Fatigue.
- Anorexia.
- Weight loss.
- Generalized aching.
- Localized tenderness.
- Anemia (anemia of chronic disease).
- Rheumatoid nodules.
- Pleuritis and pericarditis.
- Neuropathy and scleritis.
- Potential for vasculitis and renal disease.
- Pattern of exacerbations and remissions, which may involve few joints or progress relentlessly.Diagnostic Criteria
- Essential for identifying RA:
- Positive rheumatoid factor (moderately specific).
- Caution: positive rheumatoid factor does not confirm RA; associated with other conditions (e.g., lupus, infections).
- Importance of being aware of other factors that may influence positive results.
- Specific antibodies to measure:
- Anti-citrullinated protein antibodies (ACPA).
- Anti-cyclic citrullinated peptide antibodies (CCPs).
- Importance of additional tests:
- Erythrocyte sedimentation rate (ESR).
- C-reactive protein (CRP).
- Indicators of inflammation; not specific to RA.
Pathophysiology and Etiology of RA
Genetic and Environmental Components
- Polygenic nature of disease; multiple genes contribute.
- Role of environmental triggers in disease onset.
- Association with major histocompatibility complex (MHC/HLA) genes.Immune Mechanisms
- Innate immune system activation leads to joint inflammation.
- Antigen presenting cells present to the adaptive immune system.
- Activation of T cells and B cells results in:
- Release of inflammatory cytokines (tumor necrosis factor, interleukins).
- Increased antibody production targeting foreign proteins in joints.
- Breakdown of cartilage and bone, creating thickened synovium (pannus).
- Involvement of macrophages and the complement system in the inflammatory cascade.Clinical Implications
- Importance of stopping the inflammatory process promptly.
- Often, symptoms of systemic disease arise before patient report.
- Highlighted need for early diagnosis and prompt referral to specialists.
Management of RA
Role of Primary Care Providers
- Educate patients about chronic disease management.
- Non-pharmacological measures (cognitive behavioral interventions, physical and occupational therapy).
- Coordination with rheumatologists for medication management (DMARDs, corticosteroids).Monitoring and Follow-Up
- Regularly check labs for:
- CBC for anemia.
- Liver and kidney functions due to medication risks.
- Eye exams, particularly for patients on immunosuppressive therapy.
- Importance of interprofessional collaboration to manage comorbidities and monitor for infections.
Complications of RA Treatment
- Mistakes in Management
- Risks if medications are not managed appropriately, leading to severe infections.
- Consideration of halting immunosuppressive drugs in the context of new infections.
Transition to Juvenile Idiopathic Arthritis (JIA)
Introduction to JIA
- Previously known as juvenile rheumatoid arthritis.
- Similar pathophysiology to adult RA: synovitis, accumulation of synovial fluid, and panus formation.Epidemiology
- Peak incidence between ages 1-3 years, with a noted increase in girls.
- Secondary peak in ages 8-10 with higher incidence in boys.
- Higher prevalence among Caucasians.Clinical Manifestations
- Symptoms in children include:
- Fever, arthritis, rashes, lymphadenopathy.
- Laboratory abnormalities: granulocyte leukocytosis, elevated ESR/CRP, hyperferritinemia.
- Concerns regarding growth plate damage due to inflammatory processes.Management Approaches
- Treatment typically involves:
- Non-steroidal anti-inflammatory drugs (NSAIDs).
- Glucocorticoids for severe flares.
- Importance of specialist management for better outcomes.